Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alex azar
alirocumab
american patients first
bill &
biosimilars
center for medicare and medicaid services
craig garthwaite
cvs health
democrats
department of health and human services
donald
donald trump
What
details
3
×
long
3
×
awaited
drug
house
lower
plan
prices
afternoon
anathema
ancestry
anticipated
blueprint
come
component
conditions
cost
cut
democrat
dna
driven
drugs
elements
health
heavy
leaked
light
list
look
meant
medical
monday
night
pledges
potential
prescription
president
provides
results
review
Language
unset
Current search:
long
×
details
×
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@pcworld.com
4 years ago
TellMeGen review: Heavy on DNA-driven health results, but light on ancestry
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
